崔力元;陈军;

• 1:天津医科大学总医院肺部肿瘤外科

摘要(Abstract)：

肺移植是良性终末期肺疾病唯一有效的治疗方式。随着供者肺组织保存方法和手术技术水平的不断提高,肺移植手术得以广泛开展,目前该技术已趋于成熟。然而,由于肺独特的解剖结构和生理功能,导致肺部手术围术期并发症较为复杂,如何控制术后并发症、改善肺移植受者预后、延长患者术后生存期等问题逐渐成为研究的焦点,原发性移植物功能丧失(primary graft dysfunction,PGD)是肺移植术后早期发生率较高的一种并发症,也是威胁肺移植受者生存的重要因素。本文将对肺移植术后PGD发生机制、危险因素、诊断、预防及治疗等进行系统综述。

关键词(KeyWords)： 肺移植;原发性移植物功能丧失;危险因素;治疗;预防

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(81773207);; 天津市自然科学基金重点项目(16JCZDJC34200)

作者(Authors): 崔力元;陈军;

参考文献(References)：

• [1]Dalton ML.The first lung transplant[J].Am Surg,2004,70(4):364-365.
• [2]Toronto Lung Transplant Group.Unilateral Lung Trans plantation for Pulmonary Fibrosis[J].N Engl J Med,1986,314(18):1140-1145.
• [3]Chambers DC,Yusen RD,Cherikh WS,et al.The Registry of the International Society for Heart and Lung Transplantation:Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017;Focus Theme:Allograft ischemic time[J].J Heart Lung Transplant,2017,36(10):1047-1059.
• [4]张涛,洪文娟,洪志鹏.肺移植的近况及展望[J].中华肺部疾病杂志,2012,5(5):50-53.
• [5]Lee JC,Christie JD,Keshavjee S.Primary graft dysfunction:definition,risk factors,short and long-term outcomes[J].Semin Respir Crit Care Med,2010,31(2):161-171.
• [6]Suzuki Y,Cantu E,Christie JD.Primary Graft Dysfunction[J].Semin Respir Crit Care Med,2013,34(3):305-319.
• [7]Diamond JM,Lee JC,Kawut SM,et al.Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation[J].Am J Respir Crit Care Med,2013,187(5):527-534.
• [8]Porteous MK,Diamond JM,Christie JD.Primary graft dysfunction:lessons learned about the first 72 h after lung transplantation[J].Curr Opin Organ Transplant,2015,20(5):506-514.
• [9]Snell GI,Yusen RD,Weill D,et al.Report of the ISHLTWorking Group on Primary Lung Graft Dysfunction,part I:Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation[J].J Heart Lung Transplant,2017,36(10):1097-1103.
• [10]Whitson BA,Nath DS,Johnson AC,et al.Risk factors for primary graft dysfunction after lung transplantation[J].J Thorac Cardiovasc Surg,2006,131(1):73-80.
• [11]Weyker PD,Webb CA,Kiamanesh D,et al.Lung Ischemia Reperfusion Injury A Bench-to-Bedside Review[J].Semin Cardiothorac Vasc Anesth,2013,17(1):28-43.
• [12]den Hengst WA,Gielis JF,Lin JY,et al.Lung ischemia-reperfusion injury:a molecular and clinical view on a complex pathophysiological process[J].Am J Physiol Heart Circ Physiol,2010,299(5):H1283-H1299.
• [13]Chen GY,Nu?ez G.Sterile inflammation:sensing and reacting to damage[J].Nat Rev Immunol,2010,10(12):826-837.
• [14]Laubach VE,Sharma AK.Mechanisms of Lung IschemiaReperfusion Injury[J].Curr Opin Organ Transplant,2016,21(3):246-252.
• [15]Monticelli LA,Sonnenberg GF,Artis D.Innate lymphoid cells:critical regulators of allergic inflammation and tissue repair in the lung[J].Curr Opin Immunol,2012,24(3):284-289.
• [16]Goto R,Issa F,Heidt S,et al.Ischemia-Reperfusion Injury Accelerates Human Antibody-Mediated Transplant Vasculopathy[J].Transplantation,2013,96(2):139-145.
• [17]Slama A,Schillab L,Barta M,et al.Standard donor lung procurement with normothermic ex vivo lung perfusion:a prospective randomized clinical trial[J].J Heart Lung Transplant,2017,36(7):744-753.
• [18]纪勇,陈静瑜,郑明峰,等.肺移植术后早期原发性移植物失功的危险因素与防治[J].中华胸心血管外科杂志,2017,33(12):738-742.
• [19]Shigemura N,Orhan Y,Bhama JK,et al.Delayed chest closure after lung transplantation:techniques,outcomes,and strategies[J].J Heart Lung Transplant,2014,33(7):741-748.
• [20]Shigemura N,Bhama J,Gries CJ,et al.Lung transplantation in patients with prior cardiothoracic surgical procedures[J].Am JTransplant,2012,12(5):1249-1255.
• [21]Oto T,Griffiths AP,Levvey B,et al.A donor history of smoking affects early but not late outcome in lung transplantation[J].Transplantation,2004,78(4):599-606.
• [22]Pelaez A,Mitchell PO,Shah NS,et al.The Role of Donor Chronic Alcohol Abuse in the Development of Primary Graft Dysfunction in Lung Transplant Recipients[J].Am J Med Sci,2015,349(2):117-123.
• [23]Yamamoto S,Yamane M,Yoshida O,et al.Activations of mitogen-activated protein kinases and regulation of their downstream molecules after rat lung transplantation from donors after cardiac death[J].Transplant Proc,2011,43(10):3628-3633.
• [24]Oto T,Excell L,Griffiths AP,et al.The Implications of Pulmonary Embolism in a Multiorgan Donor for Subsequent Pulmonary,Renal,and Cardiac Transplantation[J].J Heart Lung Trans plant,2008,27(1):78-85.
• [25]Singer JP,Peterson ER,Snyder ME,et al.Body composition and mortality after adult lung transplantation in the United States[J].Am J Respir Crit Care Med,2014,190(9):1012-1021.
• [26]Fang A,Studer S,Kawut SM,et al.Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis[J].Chest,2011,139(4):782-787.
• [27]Porteous MK,Ky B,Kirkpatrick JN,et al.Diastolic Dysfunction Increases the Risk of Primary Graft Dysfunction After Lung Transplantation[J].Am J Respir Crit Care Med,2016,193(12):1392-1400.
• [28]张锋,许红阳,姜淑云,等.术前肺动脉舒张压对特发性肺纤维化患者双肺移植术后原发性移植物失功的预测价值[J].中华危重病急救医学,2017,29(5):442-447.
• [29]Entezari M,Javdan M,Antoine DJ,et al.Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury[J].Redox Biol,2014,2:314-322.
• [30]de Perrot M,Fischer S,Liu M,et al.Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury:a shift from pro-to anti-inflammatory cytokines[J].Transplantation,2001,72(9):1505-1512.
• [31]Botha P,Jeyakanthan M,Rao JN,et al.Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation[J].J Heart Lung Transplant,200,26(11):1199-1205.
• [32]Ruberto F,Bergantino B,Testa MC,et al.Low-Flow Venovenous CO2,Removal in Association with Lung Prote ctive Ventilation Strategy in Patients Who Develop Severe Progr e ssive Respiratory Acidosis After Lung Transplantation[J].Trans plant Proc,2013,45(7):2741-2745.
• [33]Cottini SR,Wenger U,Sailer S,et al.Extracorporeal membrane oxygenation:beneficial strategy for lung transplant recipients[J].J Extra Corpor Technol,2013,45(1):16-20.
• [34]Bittner HB,Lehmann S,Rastan A,et al.Outcome of extracorporeal membrane oxygenation as a bridge to lung transplantation and graft recovery[J].Ann Thorac Surg,2012,94(3):942-950.
• [35]Kawut SM,Lederer DJ,Keshavjee S,et al.Outcomes after lung retransplantation in the modern era[J].Am J Respir Crit Care Med,2008,177(1):114-120.
• [36]Valeuza F,Rosso L,Coppola S,et al.Ex vivo lung perusion to improve donor lung function and increase the number of organs avail able for transplantation[J].Transpl Int,2014,27(6):553-561.
• [37]Motoyama H,Chen F,Hijiya K,et al.Plasmin administration during ex vivo lung perfusion ameliorates lung ischemia-reperfusion injury[J].J Heart Lung Transplant,2014,33(10):1093-1099.
• [38]Pizanis N,Heckmann J,Wendt D,et al.Improvement of pulmonary microcirculation after lung transplantation using phosphodiesterase-5 inhibitor modified preservation solution[J].Eur J Cardiothorac Surg,2009,35(5):801-806.
• [39]Diamond JM,Cantu E,Porteous MK,et al.Peripheral Blood Gene Expression Changes Associated with Primary Graft Dysfunction After Lung Transplantation[J].Am J Transplant,2017,17(7):1770-1777.